Neurology 1012 - Neurology Alert - Dec 01, 2006

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew E. Fink, MD
Vice Chairman
Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke
and Critical Care Neurology
NewYork-Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman
Department of Neurology
Cornell University Medical College
New York, NY

Authors
Philip E. Stieg, MD, PhD
Professor and Chairman
Department of Neurological Surgery
Weill Medical College of Cornell University;
Neurosurgeon-In-Chief
New York Presbyterian Hospital

Gregg L. Caporaso, MD, PhD
Assistant Professor
Neurology and Neuroscience
Weill Cornell Medical College

Gunnar Gouras, MD
Associate Professor
Neurology and Neuroscience
Weill Medical College
Cornell University

Cynthia L. Harden, MD
Associate Professor
Neurology and Neurosciences
Weil Cornell Medical Center
Cornell University

Assistant Editors
Dana Leifer, MD
Associate Professor
Clinical Neurology
Weill Medical College
Cornell University

Claire Henchcliffe, MD, DPhil
Assistant Professor
Department of Neurology
Weill Medical College
Cornell University

Subjects:

  • Severe Symptomatic Carotid Artery Stenosis — Endarterectomy or Stenting?
  • HRT — It Can Increase Seizure Frequency in Postmenopausal Women with Epilepsy
  • High-Dose Cyclophosphamide in MS
  • TIA Management: Emphasis on Urgent Evaluation and Treatment
  • Dementia in Celiac Disease
  • Parkinson's Disease with Camptocormia: A Central or Peripheral Etiology?

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert’s physician editor, Matthew E. Fink, MD, reports no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study. Authors Philip E. Stieg, MD, PhD, Gregg L. Caporaso, MD, PhD, and Gunnar Gouras, MD, and assistant editor Dana Leifer, MD report no financial relationships relevant to this field of study. Author Cynthia L. Harden, MD does research for Schwarz, GlaxoSmithKline, UCB, Ortho, and Ivax, is a consultant for Cyberonics and GlaxoSmithKline, and is on the speaker’s bureau for Cyberonics, GlaxoSmithKline, UCB, Novartis, Pfizer, and Ortho. Assistant editor Claire Henchcliffe, MD, DPhil is on the speaker’s bureau for GlaxoSmithKline, Teva / Eisai, and Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.